Glenmark Pharma looking to launch new products across geographies
Glenmark Pharmaceuticals on Friday reported a 3.4 percent decline in net profit to Rs 239.75 crore on a 13.9 percent rise in net sales to Rs 3,141.47 crore in Q3 December 2021 over Q3 December 2020. VS Mani, Executive Director and Global CFO discussed the earnings fineprint and business outlook.
Glenmark Pharmaceuticals on Friday reported a 3.4 percent decline in net profit to Rs 239.75 crore on a 13.9 percent rise in net sales to Rs 3,141.47 crore in Q3 December 2021 over Q3 December 2020. VS Mani, Executive Director and Global CFO discussed the earnings fineprint and business outlook.
On the back of a couple of good launches, Mani is hoping to have a better sales growth, higher single-digit growth, in the coming quarter.
The company is looking at launching new products across geographies. In spite of some pressures, he hopes to manage the margins at around 19 percent for next year as well.
Also Read:
For the full interview, watch the accompanying video
Catch all stock market updates here
First Published: Feb 14, 2022 2:19 PM IST
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
Prajwal Revanna Sexual Assault Case: Activist raises concerns over political interference, delayed investigation in the matter
Apr 30, 2024 10:17 PM
Lok Sabha Election 2024: Baramati election outcome will decide the future of Pawar dynasty, says expert
Apr 30, 2024 10:08 PM
Lok Sabha elections 2024: Baramati to Mainpuri, key battles in phase 3
Apr 30, 2024 7:01 PM